Defining, evaluating, and utilizing the Target Product Profile.
Paul Tebbey
Advertisement
Paul Tebbey is Senior Director, Commercial Product Development at Genactis.
Articles by Paul Tebbey
Advertisement
Latest Updated Articles
- The Holy Grail of Product Development
May 12th 2009
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
2
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
3
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
4
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
5